Logo image of OCI.AS

OCI NV (OCI.AS) Stock Fundamental Analysis

AMS:OCI - Euronext Amsterdam - NL0010558797 - Common Stock - Currency: EUR

7.365  +0.02 (+0.2%)

Fundamental Rating

2

OCI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 62 industry peers in the Chemicals industry. OCI has a bad profitability rating. Also its financial health evaluation is rather negative. OCI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

OCI had negative earnings in the past year.
OCI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: OCI reported negative net income in multiple years.
In the past 5 years OCI always reported a positive cash flow from operatings.
OCI.AS Yearly Net Income VS EBIT VS OCF VS FCFOCI.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

OCI has a worse Return On Assets (-5.28%) than 66.13% of its industry peers.
OCI has a worse Return On Equity (-51.53%) than 79.03% of its industry peers.
Industry RankSector Rank
ROA -5.28%
ROE -51.53%
ROIC N/A
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
OCI.AS Yearly ROA, ROE, ROICOCI.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

1.3 Margins

In the last couple of years the Profit Margin of OCI has grown nicely.
Looking at the Gross Margin, with a value of 2.23%, OCI is doing worse than 82.26% of the companies in the same industry.
OCI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for OCI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
OCI.AS Yearly Profit, Operating, Gross MarginsOCI.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400 500

More info and screens

2

2. Health

2.1 Basic Checks

OCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OCI remains at a similar level compared to 1 year ago.
The number of shares outstanding for OCI has been increased compared to 5 years ago.
OCI has a better debt/assets ratio than last year.
OCI.AS Yearly Shares OutstandingOCI.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
OCI.AS Yearly Total Debt VS Total AssetsOCI.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 0.19, we must say that OCI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.19, OCI is doing worse than 80.65% of the companies in the same industry.
The Debt to FCF ratio of OCI is 44.52, which is on the high side as it means it would take OCI, 44.52 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of OCI (44.52) is worse than 61.29% of its industry peers.
OCI has a Debt/Equity ratio of 2.03. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.03, OCI is doing worse than 85.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF 44.53
Altman-Z 0.19
ROIC/WACCN/A
WACC6.11%
OCI.AS Yearly LT Debt VS Equity VS FCFOCI.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.39 indicates that OCI should not have too much problems paying its short term obligations.
With a Current ratio value of 1.39, OCI is not doing good in the industry: 62.90% of the companies in the same industry are doing better.
OCI has a Quick Ratio of 1.37. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
OCI's Quick ratio of 1.37 is fine compared to the rest of the industry. OCI outperforms 69.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.37
OCI.AS Yearly Current Assets VS Current LiabilitesOCI.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for OCI have decreased strongly by -123.19% in the last year.
The Earnings Per Share has been growing by 105.88% on average over the past years. This is a very strong growth
The Revenue for OCI has decreased by -58.51% in the past year. This is quite bad
Measured over the past years, OCI shows a very negative growth in Revenue. The Revenue has been decreasing by -20.30% on average per year.
EPS 1Y (TTM)-123.19%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%164.52%
Revenue 1Y (TTM)-58.51%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-11.72%

3.2 Future

OCI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 71.49% yearly.
The Revenue is expected to decrease by -1.74% on average over the next years.
EPS Next Y770.92%
EPS Next 2Y251.29%
EPS Next 3Y133.31%
EPS Next 5Y71.49%
Revenue Next Year-14.75%
Revenue Next 2Y-5.25%
Revenue Next 3Y-21.85%
Revenue Next 5Y-1.74%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OCI.AS Yearly Revenue VS EstimatesOCI.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
OCI.AS Yearly EPS VS EstimatesOCI.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

OCI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 18.86, OCI is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as OCI.
The average S&P500 Price/Forward Earnings ratio is at 21.38. OCI is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 18.86
OCI.AS Price Earnings VS Forward Price EarningsOCI.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

OCI's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 32.8
EV/EBITDA N/A
OCI.AS Per share dataOCI.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OCI's earnings are expected to grow with 133.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y251.29%
EPS Next 3Y133.31%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OCI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OCI NV

AMS:OCI (4/29/2025, 11:01:02 AM)

7.365

+0.02 (+0.2%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-14 2025-03-14/amc
Earnings (Next)05-20 2025-05-20
Inst Owners32.2%
Inst Owner ChangeN/A
Ins Owners8.71%
Ins Owner ChangeN/A
Market Cap1.56B
Analysts80
Price Target14.02 (90.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend13.42
Dividend Growth(5Y)N/A
DP-36.26%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)486.8%
Min EPS beat(2)232.01%
Max EPS beat(2)741.58%
EPS beat(4)2
Avg EPS beat(4)85.49%
Min EPS beat(4)-492.57%
Max EPS beat(4)741.58%
EPS beat(8)3
Avg EPS beat(8)31.49%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)37.56%
Min Revenue beat(2)20.15%
Max Revenue beat(2)54.98%
Revenue beat(4)2
Avg Revenue beat(4)8.41%
Min Revenue beat(4)-23.05%
Max Revenue beat(4)54.98%
Revenue beat(8)5
Avg Revenue beat(8)21.58%
Revenue beat(12)9
Avg Revenue beat(12)32.19%
Revenue beat(16)12
Avg Revenue beat(16)36.43%
PT rev (1m)-14.05%
PT rev (3m)-12.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)151.4%
EPS NY rev (3m)-30.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-11.11%
Revenue NY rev (3m)-11.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.86
P/S 0.39
P/FCF 32.8
P/OCF 3.2
P/B 1.92
P/tB 2.04
EV/EBITDA N/A
EPS(TTM)-0.42
EYN/A
EPS(NY)0.39
Fwd EY5.3%
FCF(TTM)0.22
FCFY3.05%
OCF(TTM)2.3
OCFY31.28%
SpS18.96
BVpS3.83
TBVpS3.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.28%
ROE -51.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.23%
FCFM 1.18%
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
F-Score3
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF 44.53
Debt/EBITDA N/A
Cap/Depr -4159.17%
Cap/Sales 10.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 1.37
Altman-Z 0.19
F-Score3
WACC6.11%
ROIC/WACCN/A
Cap/Depr(3y)137.7%
Cap/Depr(5y)97.09%
Cap/Sales(3y)24.99%
Cap/Sales(5y)17.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-123.19%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%164.52%
EPS Next Y770.92%
EPS Next 2Y251.29%
EPS Next 3Y133.31%
EPS Next 5Y71.49%
Revenue 1Y (TTM)-58.51%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-11.72%
Revenue Next Year-14.75%
Revenue Next 2Y-5.25%
Revenue Next 3Y-21.85%
Revenue Next 5Y-1.74%
EBIT growth 1Y-118.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year56.92%
EBIT Next 3Y25.04%
EBIT Next 5Y23.97%
FCF growth 1Y-95.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.4%
OCF growth 3Y-68.9%
OCF growth 5Y-27.39%